e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Emerging strategies for airway disease treatments
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: The role of IL-17A in the pathogenesis of early infection with RSV increasing susceptibility to asthma
Zhijun Jie (Shanghai, China), Yanchao He, Wei Sun, Jindong Shi, Xiao Su, Zhijun Jie
Source:
International Congress 2015 – Emerging strategies for airway disease treatments
Session:
Emerging strategies for airway disease treatments
Session type:
Thematic Poster Session
Number:
4372
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Zhijun Jie (Shanghai, China), Yanchao He, Wei Sun, Jindong Shi, Xiao Su, Zhijun Jie. LATE-BREAKING ABSTRACT: The role of IL-17A in the pathogenesis of early infection with RSV increasing susceptibility to asthma. Eur Respir J 2015; 46: Suppl. 59, 4372
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The effect of influenza virus infection on airway inflammation in a murine model of asthma
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
A deficient immune response to viral infections predicts asthma persistence in children
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016
LATE-BREAKING ABSTRACT: Airway recruitment and anti-viral function of dendritic cells in asthmatic patients during RV-16 infection
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
TLR7 gene deficiency and early-life pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013
LATE-BREAKING ABSTRACT: The critical role of interferon-gamma signaling in the respiratory immune response to influenza infection
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013
Crucial timing of a viral component exposure to exacerbate allergen-induced asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Identification of viral species in asthma patients with and without aspirin hypersensitivity
Source: Annual Congress 2013 –Viral infections
Year: 2013
Cytokine patterns and latent viruses in patients with severe asthma and COPD
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
The role of maternal obesity in susceptibility to respiratory viral infection and exacerbation rate in pregnant women with asthma
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
The role of viral and bacterial infections on the development and exacerbations of asthma
Source: Eur Respir Mon 2012; 56: 115-127
Year: 2012
LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
Upregulation of CCL5 production in the airway epithelium at the time of the viral infection
Source: International Congress 2016 – Airway response to infection
Year: 2016
Early respiratory infections and development of asthma in the first 27 years of life
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015
Childhood asthma and infection: virus-induced exacerbations as determinants and modifiers
Source: Eur Respir J 2010; 36: 438
Year: 2010
Cytokine production of leukocytes in response to respiratory syncytial virus is suppressed by cigarette smoking and in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
Asthma patients hospitalized with influenza lack mucosal and systemic type 2 inflammation
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016
LATE-BREAKING ABSTRACT: The Guangzhou COPD exacerbation study: relationship of exacerbations with viral infections and soluble biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Th1/Th2 cytokine response in infants with lower respiratory tract infection: Can we predict wheezing?
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Infection with HRV-C during acute asthma in adults is associated with increased sputum neutrophils and self-reported severity of symptoms
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept